Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
Completed · Phase 2
Conditions studied: Lung Cancer, Neurotoxicity, Ovarian Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more tumor cells. PURPOSE: Randomized phase II double-blinded trial to study the effectiveness of paclitaxel and carboplatin given with either amifostine or placebo in patients with metastatic stage III or stage IV ovarian cancer or metastatic stage III or stage IV non-small cell lung cancer.
Key facts
- Study ID
- NCT00003072
- Run by
- University of California, San Francisco
- People needed
- 80
- Starts
- 1997-05-01
- Expected to finish
- 1998-10-01
- Last updated by the study team
- 2012-09-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Oncology Service of San Francisco General Hospital Medical Center — San Francisco, California, United States
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- UCSF/Mt. Zion Cancer Center — San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.